CD8A and B-cell non-Hodgkin lymphoma: Our data suggest that retrovirally transduced PDK1 and PDP1 induced higher metabolic capacity in CD8+ T cells with larger primary and secondary responses against MHV-68, while they induced poor protection against B cell lymphoma challenge compared with the control T cells, potentially due to the altered glutamine and fatty acid within the TME.